Thumb tendon healing: is a cast better than early movement?

NCT ID NCT06836349

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests whether keeping the thumb in a cast for four weeks after surgery reduces the risk of tendon rupture compared to the standard early active motion therapy. About 380 patients in Sweden will be randomly assigned to one of the two rehab programs. The goal is to find a balance between preventing rupture and maintaining good thumb movement and strength.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
rehabilitation regimen (immobilization in plaster cast vs. early active motion training)
What this could lead to
If immobilization works better, it could reduce the higher rupture rate in thumb tendon repairs while maintaining mobility and strength.
What could go wrong
This is a relatively small, early-stage registry trial, so results may not apply broadly. Immobilization might also lead to more stiffness or weaker recovery.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for FLEXOR TENDON INJURY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Hand- och plastikkirurgiska kliniken Linköpings Universitetssjukhus

    RECRUITING

    Linköping, Sweden

  • Handkirugiska kliniken Uppsala Akademiska Sjukhus

    RECRUITING

    Uppsala, Sweden

  • Handkirurgiska kliniken Norrlands Universitetssjukhus

    RECRUITING

    Umeå, Sweden

  • Handkirurgiska kliniken Södersjukhuset

    RECRUITING

    Stockholm, Sweden

  • Handkirurgiska kliniken Örebros Universitetssjukhus

    RECRUITING

    Örebro, Sweden

More trials for these conditions

Other studies related to the condition(s) this trial covers.